Inovio Pharmaceuticals
INO
INO
100 hedge funds and large institutions have $57.4M invested in Inovio Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
9.06% more ownership
Funds ownership: 38.97% → 48.03% (+9.1%)
1% more funds holding
Funds holding: 99 → 100 (+1)
Holders
100
Holding in Top 10
–
Calls
$2.02M
Puts
$160K
Top Buyers
| 1 | +$21.7M | |
| 2 | +$3.27M | |
| 3 | +$3.14M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.33M |
| 5 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$1.18M |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$1.5M | |
| 3 | -$1.26M | |
| 4 |
Millennium Management
New York
|
-$1.25M |
| 5 |
Renaissance Technologies
New York
|
-$580K |
